Form 8-K - Current report:
SEC Accession No. 0001140361-25-007063
Filing Date
2025-03-05
Accepted
2025-03-05 08:00:18
Documents
47
Period of Report
2025-03-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20044880_8k.htm   iXBRL 8-K 30507
2 EXHIBIT 99.1 ef20044880_ex99-1.htm EX-99.1 66917
6 ef20044880_ex99-1slide1.jpg GRAPHIC 109846
7 ef20044880_ex99-1slide2.jpg GRAPHIC 264688
8 ef20044880_ex99-1slide3.jpg GRAPHIC 147920
9 ef20044880_ex99-1slide4.jpg GRAPHIC 159570
10 ef20044880_ex99-1slide5.jpg GRAPHIC 90347
11 ef20044880_ex99-1slide6.jpg GRAPHIC 163026
12 ef20044880_ex99-1slide7.jpg GRAPHIC 179461
13 ef20044880_ex99-1slide8.jpg GRAPHIC 111882
14 ef20044880_ex99-1slide9.jpg GRAPHIC 214311
15 ef20044880_ex99-1slide10.jpg GRAPHIC 172754
16 ef20044880_ex99-1slide11.jpg GRAPHIC 145093
17 ef20044880_ex99-1slide12.jpg GRAPHIC 138164
18 ef20044880_ex99-1slide13.jpg GRAPHIC 109704
19 ef20044880_ex99-1slide14.jpg GRAPHIC 114339
20 ef20044880_ex99-1slide15.jpg GRAPHIC 145227
21 ef20044880_ex99-1slide16.jpg GRAPHIC 154450
22 ef20044880_ex99-1slide17.jpg GRAPHIC 168188
23 ef20044880_ex99-1slide18.jpg GRAPHIC 130303
24 ef20044880_ex99-1slide19.jpg GRAPHIC 113059
25 ef20044880_ex99-1slide20.jpg GRAPHIC 96146
26 ef20044880_ex99-1slide21.jpg GRAPHIC 151697
27 ef20044880_ex99-1slide22.jpg GRAPHIC 143166
28 ef20044880_ex99-1slide23.jpg GRAPHIC 117719
29 ef20044880_ex99-1slide24.jpg GRAPHIC 209204
30 ef20044880_ex99-1slide25.jpg GRAPHIC 145608
31 ef20044880_ex99-1slide26.jpg GRAPHIC 181616
32 ef20044880_ex99-1slide27.jpg GRAPHIC 190111
33 ef20044880_ex99-1slide28.jpg GRAPHIC 131398
34 ef20044880_ex99-1slide29.jpg GRAPHIC 127486
35 ef20044880_ex99-1slide30.jpg GRAPHIC 191026
36 ef20044880_ex99-1slide31.jpg GRAPHIC 179938
37 ef20044880_ex99-1slide32.jpg GRAPHIC 144805
38 ef20044880_ex99-1slide33.jpg GRAPHIC 93429
  Complete submission text file 0001140361-25-007063.txt   7053011

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA galt-20250305.xsd EX-101.SCH 4018
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20250305_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20250305_pre.xml EX-101.PRE 16068
49 EXTRACTED XBRL INSTANCE DOCUMENT ef20044880_8k_htm.xml XML 4244
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 25708889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)